Browse the glossary using this index
Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
Advanced therapy medicinal products
Advanced therapy medicinal products (ATMP) are new medical products for human use based on genes (gene therapy), cells (cell therapy), or tissues (tissue engineering). They have huge potential and open the way for new treatments of a number of diseases or injuries, such as skin in burns victims, Alzheimer's, cancer, or muscular dystrophy.
Adverse Drug Reaction
A response to a medicinal product which is harmful and unintended. Response in this context means that a causal relationship between the medicinal product and an adverse event is at least a reasonable possibility.
Adapted from the Guideline on good pharmacovigilance practices (GVP) Annex I - Definitions (Rev 3) 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/05/WC500143294.pdf
Any untoward (not favourable) medical occurrence in a patient, or clinical trial participant receiving a medicine, and which does not necessarily have a causal relationship with this treatment.
Adverse events can therefore be: any unfavourable and unintended sign (e.g. an abnormal laboratory finding), symptom, or disease temporallyassociated with the use of a medicine, whether or not considered related to the medicine.
In medical science it is the study of the causes of diseases and the factors underlying their spread.
Agence Nationale de Sécurité du Médicament et des Produits de Santé
Agencia de Evaluación de Tecnologías Sanitarias
Agencia Española de Medicamentos y Productos Sanitarios
Agencija za lijekove i medicinske proizvode
Agenţia Naţională a Medicamentului şi a Dispozitivelor Medicale
Romanian National Competent Authority